JADPRO Live 2023: Focus on Breast Cancer
This section of coverage from JADPRO Live 2023, the Annual APSHO Meeting focuses on the most important meeting news on breast cancer for oncology nurses. The meeting, which ran from November 9-12, 2023, in Orlando, Florida, featured panel discussions, abstracts, posters, and education sessions on breast cancer for oncology nurses and advanced practitioners.
A presenter from the session shares what she hopes attendees learned about improving outcomes for patients with mBC.
Christine McGinn, MSN, APRN, ACNP-BC, spoke at JADPRO Live 2023 about improving outcomes for women with mBC.
People were more likely to engage with social media content when it featured stories related to their personal circumstances.
The program hosted meetings for Black patients with mBC and patient advocates to develop educational materials.
The phase III TROPiCS-02 study compared sacituzumab govitecan, an antibody-drug conjugate, with single-agent chemotherapy.
The conference offers critical networking and learning opportunities for oncology nurses.
To examine PROs and QOL, the researchers asked patients to complete 3 PRO tools.
The combination treatment was associated with “improved effectiveness” compared with aromatase inhibitor therapy alone.
As frontline providers, APPs need to "stay educated on the plethora of information surrounding genomic assays."
The COVID-19 pandemic "presented significant additional hurdles in an already unstable and shifting environment."
All patients had estrogen receptor-positive/HER2-negative advanced breast cancer with ECOG performance status of 0 or 1.
Advertisement
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.